Medications to Treat Opioid Use Disorder Research Report (1 credit hour)

Program Summary:  This course explores current research related to medications to treat opioid use disorder.  The course offers an overview of methadone, buprenorphine, and naltrexone and compares their effectiveness and how they work.  Misconceptions, misunderstandings, and diversion risks are discussed.  The course examines opioid use disorder treatment for special populations, including those with HIV, those in the military, those in the criminal justice system, and pregnant mothers.

This course is recommended for social workers, counselors, and therapists and is appropriate for beginning and intermediate levels of practice.

“Book  Open the Course Reading Here.

Readings:  Medications to Treat Opioid Use Disorder Research Report

Course Objectives:  To enhance professional practice, values, skills and knowledge by examining medications to treat opioid use disorder and current research.

Learning Objectives:  Describe how medications to treat opioid use disorder work.  Describe misconceptions and the diversion risk for opioid use disorder treatment.  Describe opioid use disorder treatment for special populations.

Review our pre-reading study guide.

Course Available Until: December 31, 2026.

In order to purchase or take this course, you will need to log in. If you do not have an account, you will need to register for a free account.

After you log in, a link will appear here that will allow you to purchase this course.

1: Medications to treat opioid use disorder could help many people recover from opioid use disorder, but they remain highly _________utilized.
 
 
2: Methadone is a
 
 
 
3: Buprenorphine is a
 
 
 
4: Which medication has the longest history of use for opioid use disorder treatment, having been used since 1947?
 
 
 
5: Maintenance medications such as methadone and buprenorphine just substitute a new substance use disorder for an old one.
 
 
6: Opioid withdrawal symptoms might include
 
 
 
 
7: Which is an opioid receptor antagonist and therefore prevents receptor activation.
 
 
 
 
8: Treatment with methadone or buprenorphine is associated with ______________ injection drug use risk behaviors.
 
 
9: In national surveys, utlization of medications to treat opioid use disorder is very low in
 
 
 
 
10: Both methadone and buprenorphine treatment during pregnancy:
 
 
 
 

In order to purchase or take this course, you will need to log in. If you do not have an account, you will need to register for a free account.

After you log in, a link will appear here that will allow you to purchase this course.

 

Free State Social Work, LLC, provider #1235, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 9/6/2021 - 9/6/2024. Social workers completing this course receive 1 clinical continuing education credit.

Free State Social Work has been approved by NBCC as an Approved Continuing Education Provider, ACEP NO. 6605. Programs that do not qualify for NBCC credit are clearly identified. Free State Social Work is solely responsible for all aspects of the programs.

G.M. Rydberg-Cox, MSW, LSCSW is the Continuing Education Director at Free State Social Work and responsible for the development of this course.  She received her Masters of Social Work in 1996 from the Jane Addams School of Social Work at the University of Illinois-Chicago and she has over 20 years of experience.  She has lived and worked as a social worker in Chicago, Boston, and Kansas City. She has practiced for many years in the area of hospital/medical social work.  The reading materials for this course were developed by another organization.

Course Available Until: December 31, 2026.
Filed under: Addiction, Clinical, Opioids